If a novel drug prevents the reuptake of a specific neurotransmitter at a synapse in the brain, which consequence follows for signal transmission?

💡 Explanation

Preventing reuptake prolongs the neurotransmitter's presence in the synaptic cleft, leading to continued binding and prolonged signaling, because the neurotransmitter isn't cleared. Therefore, the signal is prolonged rather than terminated prematurely; receptor desensitization and neurotransmitter production halt would require different mechanisms.

• A patient undergoes bariatric surgery, reducing nutrient absorption in the small intestine. Which risk increases as mineral absorption declines, particularly for calcium and vitamin D?
• If a novel subunit vaccine administered with an adjuvant elicits a weak initial antibody response in mice, which immune mechanism's enhancement by the adjuvant is most likely deficient?
• A patient requires increasing morphine doses to manage chronic pain following surgery. Which mechanism primarily explains the reduced analgesic effect over time?
• Which process is responsible for decreasing serum calcium when calcium intake greatly exceeds renal excretion capacity?
• Why does a beta-2 adrenergic agonist inhaler relieve asthma symptoms during an attack?
• During a spinal cord injury rehabilitation program, why does chronic neuropathic pain often persist despite reduced nociceptor activation from peripheral stimuli?